6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	Appendix 4C and Quarterly Activities Report - March 2026
10m ago	Haier Biomedical Drives Global Leap of Life Science Infrastructure: International Business Hits Record High for 36% of Annual Revenue in 2025
12m ago	Correction to Austral Gold Q1 2026 Quarterly Activities Report
12m ago	Austral Gold Files Q1 2026 Quarterly Activities Report
14m ago	SFG Quarterly Activities/Appendix 4CCash Flow Report

About

Vyne Therapeutics Inc (NASDAQ:VYNE) — investor relations, events, news, and company updates on 6ix.

Latest News

VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement

VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement

VYNE Therapeutics Reports 2025 Third Quarter Financial Results and Provides Business Update

VYNE Therapeutics Reports 2025 Second Quarter Financial Results and Provides Business Update

VYNE Therapeutics Announces Topline Results from Phase 2b Trial with Repibresib Gel in Nonsegmental Vitiligo

Financials

Revenue

$570 K

Market Cap

$20.12 M

EPS

-0.63

Community Chat

Ask AI